Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma

被引：0
作者：
Wing-Lok Chan
Cheuk-Wai Choi
Ian Yu-Hong Wong
Terence Hon-Ting Tsang
Adrian Tin-Chung Lam
Rosa Pui-Ying Tse
K. K. Chan
Claudia Wong
Betty Tze-Ting Law
Emina Edith Cheung
Siu-Yin Chan
Ka-On Lam
Dora Kwong
Simon Law
机构：
[1] The University of Hong Kong,Department of Clinical Oncology, LKS Faculty of Medicine
[2] The University of Hong Kong,School of Public Health, LKS Faculty of Medicine
[3] The University of Hong Kong,Department of Surgery, LKS Faculty of Medicine
[4] The University of Hong Kong,LKS Faculty of Medicine
[5] Queen Mary Hospital,Department of Clinical Oncology
[6] Queen Mary Hospital,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：861 / 870
页数：9
相关论文
共 50 条
  • [31] Locally advanced head and neck squamous cell carcinomas treated with TPF(docetaxel, cisplatin, 5-FU) induction chemotherapy
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Honma, Rio
    Takeuchi, Satoshi
    Tsuchiya, Kazuhiko
    Shirato, Hiroki
    Homma, Akihiro
    Fukuda, Satoshi
    Akita, Hirotoshi
    ANNALS OF ONCOLOGY, 2015, 26 : 90 - 90
  • [32] Concomitant chemoradiotherapy using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with advanced sino-nasal squamous cell carcinoma.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Ikeda, Aya
    Tuchida, Kodai
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] Phase II study of docetaxel, cisplatin, and 5-FU induction chemotherapy followed by chemoradiotherapy in locoregionally advanced nasopharyngeal cancer
    Bae, Woo Kyun
    Hwang, Jun Eul
    Shim, Hyun Jeong
    Cho, Sang Hee
    Lee, Joon Kyoo
    Lim, Sang-Chul
    Chung, Woong-Ki
    Chung, Ik-Joo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 589 - 595
  • [34] Induction cisplatin, paclitaxel, and 5FU (PTF) before definitive local therapy for locally advanced esophageal squamous cell carcinoma (SCC)
    Fernandez, R.
    Lopez de Argumedo, G.
    Fuente, N.
    Ferreiro, J.
    Martinez, M.
    Azkona, E.
    Gutierrez, E.
    Iza, E.
    Casas, R.
    Mane, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [35] TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma
    Bando, Hideaki
    Kotani, Daisuke
    Tsushima, Takahiro
    Hara, Hiroki
    Kadowaki, Shigenori
    Kato, Ken
    Chin, Keisho
    Yamaguchi, Kensei
    Kageyama, Shun-ichiro
    Hojo, Hidehiro
    Nakamura, Masaki
    Tachibana, Hidenobu
    Wakabayashi, Masashi
    Fukutani, Miki
    Togashi, Yosuke
    Fuse, Nozomu
    Nishikawa, Hiroyoshi
    Kojima, Takashi
    BMC CANCER, 2020, 20 (01)
  • [36] Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU
    Azin, Marjan
    Ameri, Amir H.
    Nazarian, Rosalynn M.
    Cusack, James C.
    Tsiaras, William G.
    Asgari, Maryam M.
    Demehri, Shadmehr
    CUTIS, 2023, 112 (01): : E27 - E29
  • [37] Novel sensitivity genes to 5-FU and CDDP in esophageal squamous cell carcinoma
    Fumoto, Shoichi
    Shimokuni, Tatsushi
    Tanimoto, Keiji
    Hiyama, Keiko
    Noguchi, Tsuyoshi
    Kawahara, Katsunobu
    Otani, Keiko
    Ohtaki, Megu
    Hiyama, Eiso
    Nishiyama, Masahiko
    CANCER RESEARCH, 2006, 66 (08)
  • [38] Defining conversion therapy for esophageal squamous cell carcinoma
    Matsuda, Satoru
    Tsushima, Takahiro
    Kato, Ken
    Hsu, Chih-Hung
    Lee, Jang Ming
    Wong, Ian Yu-Hong
    Wang, Hu-Lin Christina
    Kang, Chang Hyun
    Guo, Xufeng
    Yamamoto, Shun
    Tsuji, Takayuki
    Kawakubo, Hirofumi
    Takeuchi, Hiroya
    Law, Simon
    Kitagawa, Yuko
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2023, 7 (01): : 7 - 9
  • [39] Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma
    Yuji Akiyama
    Takeshi Iwaya
    Fumitaka Endo
    Takehiro Chiba
    Takeshi Takahara
    Koki Otsuka
    Hiroyuki Nitta
    Keisuke Koeda
    Masaru Mizuno
    Yusuke Kimura
    Akira Sasaki
    Surgical Endoscopy, 2018, 32 : 391 - 399
  • [40] Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma
    Akiyama, Yuji
    Iwaya, Takeshi
    Endo, Fumitaka
    Chiba, Takehiro
    Takahara, Takeshi
    Otsuka, Koki
    Nitta, Hiroyuki
    Koeda, Keisuke
    Mizuno, Masaru
    Kimura, Yusuke
    Sasaki, Akira
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (01): : 391 - 399
12345